Deucravacitinib in Moderate to Severe Psoriasis: Clinical and Quality-of-Life Outcomes in a Phase 2 Trial

by Banerjee, S., Colombo, M.J, Elbez, Y., Foley, P., Gooderham, M., Gordon, K.B, Gottlieb, A.B, Kisa, R.M, Menter, M.A, Merola, J.F, Morita, A., Napoli, A.A, Papp, K.A, Puig, L., Strober, B., Thaçi, D., Wei, L., Ye, J.
Published 2022